HCKT
The Hackett Group, Inc.
HCKT's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over HCKT overall, supported by stronger valuation and stronger modeled upside.
HCKT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| Stable | |
| Stable |
HCKT's profitability is currently strong, and its cash flow and balance sheet are stable, but its revenue is under pressure.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
HCKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.7x | $13.44 | — |
| Cheap | 16x | $11.45 | -15% |
| Current | 19x | $13.44 | — |
| Fair | 21x | $14.55 | +8.2% |
| Expensive | 39x | $26.96 | +101% |
Historical ranges are pointers, not guarantees.
HCKT has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
HCKT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect HCKT's earnings to grow and its profitability to improve, with its revenue holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over HCKT on the outlook, with more favorable revenue expectations.
HCKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.55 | +121% |
| Q3 2026 | $0.70 | +84% |
| Q2 2026 | $0.65 | +8.3% |
| Q1 2026 | $0.53 | -38% |
| Q4 2025 | $0.47 | -56% |
| Q3 2025 | $0.38 | -69% |
| Q2 2025 | $0.60 | -52% |
| Q1 2025 | $0.85 | -33% |
| Q4 2024 | $1.06 | -15% |
HCKT's earnings per share have fallen from their peak: $0.70 over the past year, against $1.47 in late 2022.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over HCKT on earnings, with more consistent year-over-year improvement.
HCKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $69.8M | -4.5% |
| Q2 2026 | $69.3M | -12% |
| Q1 2026 | $68.8M | -12% |
| Q4 2025 | $75.8M | -4.4% |
| Q3 2025 | $73.1M | -8.4% |
| Q2 2025 | $78.9M | +1.6% |
| Q1 2025 | $77.9M | +0.9% |
| Q4 2024 | $79.2M | +9.4% |
HCKT's revenue is shrinking: $70M last quarter, down 4.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.3 points |
| Q2 2026 | 11% | +5.3 points |
| Q1 2026 | 13% | +7.3 points |
| Q4 2025 | 12% | +2.2 points |
| Q3 2025 | 7.5% | -8.6 points |
| Q2 2025 | 5.8% | -10 points |
| Q1 2025 | 5.7% | -9.3 points |
| Q4 2024 | 9.8% | -6.1 points |
HCKT's operating margin was 11% last quarter, up 3.3 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over HCKT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over HCKT on profitability, with a higher operating margin.
HCKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.3M | -115% |
| Q2 2026 | $12.6M | +237% |
| Q1 2026 | -$7.5M | -382% |
| Q4 2025 | $17.1M | -13% |
| Q3 2025 | $9M | -3.9% |
| Q2 2025 | $3.7M | -71% |
| Q1 2025 | $2.7M | +44% |
| Q4 2024 | $19.6M | -21% |
HCKT usually generates cash, though not every quarter: the latest was −$1M, but it generated $21M over the past year.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over HCKT on cash flow, with more consistent year-over-year improvement.
HCKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -213K shares |
| 1 year | -9.6% | -2.7M shares |
| 3 years | -10% | -2.9M shares |
| 5 years | -24% | -7.9M shares |
| Available history | -23% | -7.5M shares |
HCKT has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.8M |
| Q2 2026 | $3.9M |
| Q1 2026 | $3M |
| Q4 2025 | $41.2M |
| Q3 2025 | $17.4M |
| Q2 2025 | $4.3M |
| Q1 2025 | $6.2M |
| Q4 2024 | $3.6M |
HCKT spent $50M buying back its own shares over the past year, up 58% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
HCKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.0x | Moderate |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | -0.1x | Net Cash |
HCKT's net debt is about 1.9 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over HCKT on leverage, with a lower net debt burden relative to earnings.
HCKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.5 | Neutral |
| Stochastic | 84.5 | Overbought |
HCKT's weekly RSI is 60 (neutral) and its Stochastic is 84 (overbought).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
HCKT PE vs Technology Sector
| Metric | HCKT | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 28x | 31% below |
| PE % | 38 | 35 | 3 pts above |
HCKT is trading at 19x earnings, a 31% discount to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over HCKT on valuation relative to its sector.
HCKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 13% above |
| 20 week MA | $11.2 | 20% above |
| 50 week MA | $13.3 | 1% above |
| 100 week MA | $19.0 | 29% below |
| 200 week MA | $21.0 | 36% below |
HCKT has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 36% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
HCKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.9 | $14.0 | -12% |
| 2021 | $14.0 | $20.7 | +47% |
| 2022 | $20.7 | $20.5 | -0.8% |
| 2023 | $20.5 | $22.8 | +11% |
| 2024 | $22.8 | $30.9 | +36% |
| 2025 | $30.9 | $20.0 | -35% |
| 2026 YTD | $20.0 | $13.4 | -33% |
HCKT has finished lower in three of the last six years. It's down 33% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over HCKT on returns for 2026, with the stronger performance.